[{"address1": "Bellevue Centre", "address2": "Suite 300 235 -15th Street", "city": "West Vancouver", "state": "BC", "zip": "V7T 2X1", "country": "Canada", "phone": "604 921 1810", "fax": "604 921 1898", "website": "https://briacell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the\nclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. William V. Williams FCPA, M.D.", "age": 69, "title": "CEO, President & Director", "yearBorn": 1955, "fiscalYear": 2025, "totalPay": 711724, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gadi  Levin B.Com., C.A., CPA, M.B.A.", "age": 51, "title": "CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2025, "totalPay": 535361, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miguel A. Lopez-Lago Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2025, "totalPay": 447547, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Giuseppe  Del Priore M.D., M.P.H., MPH", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2025, "totalPay": 493048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Charles Louis Wiseman FACP, M.D.", "age": 78, "title": "Founder, Principal Research Advisor & Member of Scientific Advisory Board", "yearBorn": 1946, "fiscalYear": 2025, "totalPay": 241138, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 12.24, "open": 12.22, "dayLow": 11.39, "dayHigh": 12.285, "regularMarketPreviousClose": 12.24, "regularMarketOpen": 12.22, "regularMarketDayLow": 11.39, "regularMarketDayHigh": 12.285, "payoutRatio": 0.0, "beta": 1.917, "forwardPE": -29.20513, "volume": 38251, "regularMarketVolume": 38251, "averageVolume": 69485, "averageVolume10days": 56430, "averageDailyVolume10Day": 56430, "bid": 8.87, "ask": 15.38, "bidSize": 2, "askSize": 2, "marketCap": 21507190, "fiftyTwoWeekLow": 3.5, "fiftyTwoWeekHigh": 98.2, "allTimeHigh": 1563.518, "allTimeLow": 3.5, "fiftyDayAverage": 11.0472, "twoHundredDayAverage": 22.71205, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3044613, "profitMargins": 0.0, "floatShares": 1674529, "sharesOutstanding": 1883906, "sharesShort": 114893, "sharesShortPriorMonth": 103747, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.061, "heldPercentInsiders": 0.02338, "heldPercentInstitutions": 0.047519997, "shortRatio": 1.58, "shortPercentOfFloat": 0.061100002, "impliedSharesOutstanding": 1888252, "bookValue": 9.491, "priceToBook": 1.2000843, "lastFiscalYearEnd": 1753920000, "nextFiscalYearEnd": 1785456000, "mostRecentQuarter": 1753920000, "netIncomeToCommon": -26311868, "trailingEps": -62.19, "forwardEps": -0.39, "lastSplitFactor": "1:10", "lastSplitDate": 1756080000, "enterpriseToEbitda": -0.112, "52WeekChange": 0.028571486, "SandP52WeekChange": 0.13287461, "quoteType": "EQUITY", "currentPrice": 11.39, "targetHighPrice": 150.0, "targetLowPrice": 150.0, "targetMeanPrice": 150.0, "targetMedianPrice": 150.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 17866280, "totalCashPerShare": 9.484, "ebitda": -27098176, "totalDebt": 0, "quickRatio": 4.491, "currentRatio": 5.009, "returnOnAssets": -1.2356, "returnOnEquity": -3.62563, "freeCashflow": -18894308, "operatingCashflow": -28170520, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": -6.9444394, "regularMarketPrice": 11.39, "fiftyTwoWeekLowChange": 7.8900003, "fiftyTwoWeekLowChangePercent": 2.2542858, "fiftyTwoWeekRange": "3.5 - 98.2", "fiftyTwoWeekHighChange": -86.81, "fiftyTwoWeekHighChangePercent": -0.8840122, "fiftyTwoWeekChangePercent": 2.8571486, "dividendDate": 1577923200, "earningsTimestampStart": 1749758400, "earningsTimestampEnd": 1750104000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -62.19, "epsForward": -0.39, "shortName": "BriaCell Therapeutics Corp.", "longName": "BriaCell Therapeutics Corp.", "corporateActions": [], "postMarketTime": 1764979398, "regularMarketTime": 1764968400, "exchange": "NCM", "messageBoardId": "finmb_262266102", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1331731800000, "postMarketChangePercent": 3.8481135, "postMarketPrice": 11.8283, "postMarketChange": 0.43830013, "regularMarketChange": -0.8499994, "regularMarketDayRange": "11.39 - 12.285", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 69485, "fiftyDayAverageChange": 0.34280014, "fiftyDayAverageChangePercent": 0.0310305, "twoHundredDayAverageChange": -11.322049, "twoHundredDayAverageChangePercent": -0.49850407, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-24", "cryptoTradeable": false, "displayName": "BriaCell Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]